Clinical Trials Directory

Trials / Recruiting

RecruitingNCT06374615

Insights Into Tick-Borne Diseases: a Study From an Endemic Area of Northern Italy

Insights Into Tick-Borne Diseases: a Prospective Study From an Endemic Area of Northern Italy

Status
Recruiting
Phase
N/A
Study type
Interventional
Enrollment
384 (estimated)
Sponsor
IRCCS Sacro Cuore Don Calabria di Negrar · Academic / Other
Sex
All
Age
8 Years
Healthy volunteers
Not accepted

Summary

This is a monocentric, experimental, non-pharmacological and non-device no profit study. The study is experimental because all the visits and blood withdrawals foreseen by the protocol do not fall within the normal clinical practice.

Conditions

Interventions

TypeNameDescription
DIAGNOSTIC_TESTIgG and IgM search for specific Tick-Borne PatogensTicks will be classified based on morphological characteristics by microscopy observation. For TBP detection by molecular test, Nucleic acid extraction will be performed on ticks lysate or blood using kits MagMAX TM Viral/Pathogen Nucleic Acid Isolation Kit (Thermo Fisher Scientific) on MagEX STARlet platform from Hamilton. Species identification by molecular method will be performed by Sanger sequencing for Rickettsiae and Babesia, and Multi-Locus Sequence Typing will be used to characterize Borrelia. Serum samples collected throughout the study will be tested to assess any seroconversions during the follow-up period. Samples will be tested for the presence of specific IgG and IgM for the following TBPs: TBEV, R. typhi. R. conorii, Borrelia spp, Anaplasma, Ehrlichia and Babesia.

Timeline

Start date
2024-03-25
Primary completion
2029-03-01
Completion
2029-03-01
First posted
2024-04-18
Last updated
2024-04-18

Locations

1 site across 1 country: Italy

Source: ClinicalTrials.gov record NCT06374615. Inclusion in this directory is not an endorsement.